Chinese clinical expert consensus on surgical treatment of myasthenia gravis
- VernacularTitle:重症肌无力外科治疗中国临床专家共识
- Author:
Qunyou TAN
1
;
Shaolin TAO
1
;
Baodong LIU
2
;
Yangchun LIU
3
Author Information
1. Department of Thoracic Surgery, Daping Hospital, Army Medical University, Chongqing, 400042, P. R. China
2. Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, P. R. China
3. Department of Thoracic Surgery, Jiangxi Provincial People's Hospital, Nanchang, 330006, P. R. China
- Collective Name:Representatives of the Consensus Writing Group of China Myasthenia Gravis Alliance
- Publication Type:Journal Article
- Keywords:
Myasthenia gravis;
surgical treatment;
extended thymectomy;
expert consensus
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(05):529-541
- CountryChina
- Language:Chinese
-
Abstract:
Myasthenia gravis (MG) is an autoimmune disease with indefinite pathogenesis. MG is closely related to thymic diseases, and thymectomy is an important way for MG treatment. However, there are some controversies regarding thymectomy, including indications, operation opportunities, operative procedures, surgical approaches, perioperative managements, and efficacy evaluations, etc. Therefore, based on the literature and the experience of Chinese experts, this consensus has been written after careful discussion and inquiry and 29 recommendations have been made, aiming to guide surgical treatment of MG and improve the clinical outcomes.
